V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190009636 | 190007513 | 1.59 | 48.4 | Palliative (P) | 2021-04-08 | 2021-04-18 | MAP | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100342245 |
| 190009668 | 190007514 | 1.71 | 69.8 | Palliative (P) | 2020-03-04 | 2020-03-08 | PAM x 2 pre-surgery (cycles 1&2) | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100473939 |
| 190009699 | 190007515 | 0 | 64.4 | Palliative (P) | 2016-08-11 | 2016-08-19 | EW EuroEwing 2012 Arm B VC | 02 | N | EW EUROEWING 2012 ARM B VC | 101276424 |
| 190009744 | 190007516 | 1.46 | 36 | null | 2016-02-09 | 2016-07-28 | Doxorubicin 75mg/m2 | 01 | N | DOXORUBICIN | 100054242 |
| 190009746 | 190007517 | null | 67 | Palliative (P) | 2021-09-19 | 2021-09-23 | DHAP | 02 | N | EW EUROEWING 2012 ARM A VAI | 100319042 |
| 190009759 | 190007518 | 1.64 | 54 | Palliative (P) | 2020-08-28 | 2020-11-04 | CISPLATIN + RT | 02 | null | DACARBAZINE | 100644042 |
| 190009761 | 190007519 | 0 | 43.5 | Curative (C) | 2017-09-19 | 2018-04-19 | EW Rel rEECur Irinotecan/Temozolomide | 02 | N | EURAMOS TRIAL | 100077199 |
| 190009770 | 190007521 | 1.11 | 40 | Curative (C) | 2017-06-20 | 2017-12-31 | Ifosfamide | 02 | null | TRIAL | 101800305 |
| 190009780 | 190007522 | 1.71 | 64.6 | Palliative (P) | 2020-01-25 | 2020-02-21 | EW Rel Irinotecan & Temozolomide | 01 | N | NOT MATCHED | 100020687 |
| 190009815 | 190007524 | 0 | 34.3 | null | 2020-05-11 | 2020-06-19 | OST Euramos 1 Closed Trial - M | 1 | Y | OST M | 101573241 |
| 190009824 | 190007525 | 1.74 | 89.1 | Curative (C) | 2019-08-21 | 2019-11-24 | Trial Unspecified | 02 | N | IRINOTECAN + TEMOZOLOMIDE | 101041721 |
| 190009840 | 190007526 | 0 | 56.9 | Adjuvant (A) | 2018-09-10 | 2018-09-11 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | CAV | 100295606 |
| 190009842 | 190007527 | 1.6 | 50.7 | Curative (C) | 2017-10-06 | 2018-04-09 | PEMBROLIZUMAB | 02 | null | EURO-EWING | 100070652 |
| 190009865 | 190007528 | 0 | 59.7 | Neo-adjuvant (N) | 2021-07-05 | 2021-08-03 | EW EuroEwing 2012 Arm B IE | 02 | null | EW EUROEWING 2012 ARM B IE | 100326896 |
| 190009878 | 190007529 | 0 | 40.5 | Curative (C) | 2019-08-09 | 2019-09-07 | METHOTREXATE | N | N | METHOTREXATE | 100482626 |
| 190009884 | 190007530 | 0 | 20.5 | Curative (C) | 2019-01-18 | 2019-02-25 | Dox + HD Mtx (post PAM) | 02 | N | DHAP | 101798406 |
| 190009897 | 190007531 | 1.74 | 88.4 | null | 2019-10-19 | 2019-11-16 | OST Euramos 1 Closed Trial - M | 02 | N | OST M | 101513878 |
| 190009905 | 190007532 | 0 | 42.6 | Palliative (P) | 2019-05-17 | 2019-09-29 | DOCETAXEL + GEMCITABINE | 02 | N | DOCETAXEL + GEMCITABINE | 100935290 |
| 190009910 | 190007533 | 0 | 51 | Palliative (P) | 2015-06-19 | 2016-06-05 | DOXORUBICIN | null | null | DOXORUBICIN | 101791109 |
| 190009914 | 190007534 | 1.55 | 88.3 | null | 2018-06-21 | 2018-12-18 | OST Rel Ifosfamide Etoposide Mtx | 02 | N | NB HRNBL-1 BUMEL MAT | 101292391 |
| 190009917 | 190007535 | 0 | 26.7 | Palliative (P) | 2021-12-06 | 2021-12-07 | OST Euramos 1 Closed Trial - M | 01 | N | OST M | 100316004 |
| 190009931 | 190007536 | 1.46 | 18.9 | Palliative (P) | 2020-07-16 | 2020-09-02 | ETOPOSIDE + IFOSFAMIDE + MESNA | 02 | N | ETOPOSIDE + IFOSFAMIDE | 100621537 |
| 190009950 | 190007537 | 1.74 | 84.1 | Neo-adjuvant (N) | 2019-07-15 | 2020-03-28 | DOXORUBICIN | null | null | DOXORUBICIN | 100607227 |
| 190009977 | 190007538 | 0 | 19.4 | Palliative (P) | 2019-10-06 | 2019-12-27 | CARBOPLATIN + PACLITAXEL + RT | null | null | OST MIFAMURTIDE | 101725784 |
| 190010002 | 190007539 | 1.51 | 48.8 | null | 2019-11-20 | 2020-04-01 | OST Euramos 1 Closed Trial - A | 02 | null | OST A | 100064157 |
| 190010035 | 190007540 | 0 | 73.8 | Palliative (P) | 2020-11-03 | 2020-11-15 | EW EuroEwing 2012 Arm B IE | 02 | N | EW EUROEWING 2012 ARM B IE | 101667228 |
| 190010044 | 190007541 | 0 | 61 | Adjuvant (A) | 2022-03-15 | 2022-03-22 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101484428 |
| 190010045 | 190007542 | 1.63 | 54.6 | Curative (C) | 2019-12-24 | 2020-01-06 | CARBOPLATIN + ETOPOSIDE | 02 | N | BRENTUXIMAB | 100182411 |
| 190010079 | 190007543 | 0 | 49.4 | Curative (C) | 2018-12-07 | 2019-03-01 | OST Euramos 1 Closed Trial - A | 02 | null | OST A | 100830105 |
| 190010085 | 190007544 | 1.57 | 94.4 | Curative (C) | 2016-12-12 | 2016-12-27 | Etoposide oral | 02 | N | CAV | 100022744 |
| 190010086 | 190007545 | 0 | 39.2 | Palliative (P) | 2021-06-04 | 2022-01-05 | VAI (Ifos 3g/m2) | 02 | N | PACLITAXEL | 100813051 |
| 190010091 | 190007546 | 1.74 | 58.8 | Curative (C) | 2020-08-21 | 2020-10-16 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101727589 |
| 190010093 | 190007547 | 1.95 | null | Palliative (P) | 2021-12-12 | 2021-12-15 | CarboPEC-Taxol | 02 | N | DOXORUBICIN + METHOTREXATE | 101125124 |
| 190010117 | 190007549 | 1.79 | 81.6 | Curative (C) | null | 2021-05-15 | EW EuroEwing 2012 Arm B IE | 02 | null | EW EUROEWING 2012 ARM B IE | 100494715 |
| 190010122 | 190007550 | 0 | 0 | null | 2018-08-07 | 2019-05-01 | GemCarbo Days 1+8 | N | N | EW REL REECUR IRINOTECAN/TEMOZOLOMIDE | 100562215 |
| 190010126 | 190007551 | 1.88 | 71.1 | null | null | 2020-08-26 | PAM x 2 post-surgery (cycles 3&4) | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100810176 |
| 190010131 | 190007553 | 0 | 45.3 | null | 2019-01-15 | 2019-01-20 | NB HRNBL-1 ch14.18/CHO only (trial) | N | N | EW EUROEWING 2012 ARM A VAI | 101245049 |
| 190010137 | 190007554 | 1.6 | 94.3 | Curative (C) | 2018-06-14 | 2018-06-16 | MAP | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100807503 |
| 190010150 | 190007555 | 1.51 | 45 | Palliative (P) | 2018-08-02 | 2019-03-27 | EW EuroEwing 2012 Arm B VDC | 01 | N | NOT MATCHED | 100080628 |
| 190010151 | 190007556 | 0 | 30.7 | Adjuvant (A) | 2019-11-13 | 2019-11-13 | NB HRNBL-1 COJEC Ind COURSE C | null | null | CISPLATIN + FLUOROURACIL | 101185899 |
| 190010178 | 190007557 | 0 | 79.1 | Neo-adjuvant (N) | 2019-11-23 | 2020-03-30 | Irinotecan + Modified De Gramont | 02 | N | METHOTREXATE HIGH DOSE | 101243503 |
| 190010184 | 190007558 | 0 | 0 | Adjuvant (A) | 2019-04-18 | 2019-05-23 | Trial Unspecified | 01 | N | CARBOPLATIN + ETOPOSIDE | 101784800 |
| 190010215 | 190007559 | 1.7 | 98.4 | null | 2020-02-12 | 2020-03-10 | Gemcitabine day 1&8 | 02 | N | ETOPOSIDE | 100957220 |
| 190010254 | 190007560 | 0 | 0 | Curative (C) | 2017-10-21 | 2018-02-24 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + METHOTREXATE + VINCRISTINE | Y | N | ETOPOSIDE | 101655316 |
| 190010259 | 190007562 | 0 | 52.2 | null | 2019-04-19 | 2019-05-21 | ETOPOSIDE + IFOSFAMIDE | 02 | null | ETOPOSIDE + IFOSFAMIDE | 101864734 |
| 190010293 | 190007563 | 0 | 37.4 | Curative (C) | 2018-09-28 | 2018-10-01 | DHAP | 02 | null | NB HRNBL-1 COJEC IND COURSE C | 101826975 |
| 190010295 | 190007564 | 0 | 12.7 | Adjuvant (A) | 2021-05-05 | 2021-05-24 | Capecitabine | 02 | null | ETOPOSIDE | 101658414 |
| 190010298 | 190007565 | 1.73 | 82 | Curative (C) | 2018-02-25 | 2018-03-31 | CYCLO + DOXORUBICIN + VINCRISTINE | 01 | N | CARBOPLATIN + ETOPOSIDE | 101616146 |
| 190010303 | 190007566 | null | 27.5 | Curative (C) | 2015-11-04 | 2016-04-20 | OST Euramos 1 Closed Trial - IE | null | null | DOXORUBICIN + OLARATUMAB | 100662844 |
| 190010347 | 190007567 | 0 | 89.8 | Neo-adjuvant (N) | 2017-04-06 | 2017-04-21 | Trial Unspecified | 01 | N | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 100457965 |